Kura Oncology (KURA) Change in Accrued Expenses (2009 - 2026)
Kura Oncology's Change in Accured Expenses was $9.66 million in Q2 2026, down 7.2% from $10.41 million a year earlier.
Powered by 
Analysis
Kura Oncology (KURA) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kura Oncology's Change in Accured Expenses was $4.3 million through Jun 30, 2026, down 80.3% year-over-year; for FY2025, it came in at $12.65 million, down 24.8% from FY2024.
- Change in Accured Expenses shows a five-year compound annual growth rate of 17.4% (FY2020 to FY2025).
- In earlier years, Change in Accured Expenses was $16.83 million in FY2024 (+49.6%), $11.25 million in FY2023, -$802,000 in FY2022 and -$2.52 million in FY2021.
- Quarterly Change in Accured Expenses has moved between -$16.22 million (Q1 2026) and $14.33 million (Q4 2024) over five years.
- Compared with a year earlier, Change in Accured Expenses was higher in three of the last four quarters, with growth averaging 58.4%.
- Per Business Quant data, KURA's Change in Accured Expenses in the three quarters before Q2 2026 was -$16.22 million (Q1 2026), -$2.16 million (Q4 2025) and $13.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Kura Oncology | 695.52 Mn | -1.56 Bn | 22.47 Mn | 12.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.17 Mn |
| Jun 30, 2026 | 9.66 Mn |
| Mar 31, 2026 | -16.22 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Mar 31, 2025 | -8.61 Mn |
| Dec 31, 2024 | 14.33 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | -50,000.00 |
| Mar 31, 2024 | -3.13 Mn |
| Dec 31, 2023 | 8.57 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | -5.36 Mn |
| Dec 31, 2022 | -1.56 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | -341,000.00 |
| Mar 31, 2022 | -5.25 Mn |
| Dec 31, 2021 | 31,000.00 |
API Access
Kura Oncology Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();